Search Results - "Au, Trang H."

The Prevention of Contrast-Induced Nephropathy by Au, Trang H., Bruckner, Anne, Mohiuddin, Syed M., Hilleman, Daniel E.

“…Objective: Contrast-induced nephropathy (CIN) is a complication which may develop after exposure to iodinated contrast media. The resulting acute kidney injury…”
Get full text

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma by Stenehjem, David D, Hahn, Andrew W, Gill, David M, Albertson, Daniel, Gowrishankar, Banumathy, Merriman, Joseph, Agarwal, Archana M, Thodima, Venkata, Harrington, Erik B, Au, Trang H, Maughan, Benjamin L, Houldsworth, Jane, Pal, Sumanta K, Agarwal, Neeraj

“…First-line treatment for metastatic renal cell carcinoma (mRCC) is rapidly changing. It currently includes VEGF targeted therapies (TT), multi-target tyrosine…”
Get full text

Hepatitis C therapy: Looking toward interferon-sparing regimens by Au, Trang H., PharmD, MPH, Destache, Christopher J., PharmD, FCCP, Vivekanandan, Renuga, MD

“…Abstract Objective To describe chronic hepatitis C virus (HCV) infection, including its epidemiology and pathophysiology; review current treatment options for…”
Get full text

Evaluation of the relevance and access of EHR-based variables to support personalized medicine in breast cancer by Stenehjem, David D., Udomaksorn, Siripa, Cheng, Yan, Pflieger, Lance, Au, Trang H., Buys, Saundra S., Brixner, Diana I.

“…Background: The increasing number of available cancer therapies render medical decision-making (MDM) less straightforward. Patients want to know about the…”
Get full text

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma by Au, Trang H., Willis, Connor, Reblin, Maija, Peters, Katherine B., Nghiemphu, Phioanh Leia, Taylor, Jennie W., Colman, Howard, Cohen, Adam L., Ormond, D. Ryan, Chakravarti, Arnab, Willmarth, Nicole, Menon, Jyothi, Ma, Junjie, Bauer, Hillevi, Watanabe, Alexandre H., Ulrich, Cornelia M., Singh, Prianka, Marshall, Alexander, Korytowsky, Beata, Stenehjem, David, Brixner, Diana

“…Background Glioblastoma is an incurable disease with a poor prognosis. For caregivers of people with glioblastoma, the burden of care can be high. Patients…”
Get full text

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? by Biltaji, Eman, Walker, Brandon, Au, Trang H, Rivers, Zachary, Ose, Jennifer, Li, Christopher I, Brixner, Diana I, Stenehjem, David D, Ulrich, Cornelia M

“…Inherited genetic variants can modify the cancer-chemopreventive effect of aspirin. We evaluated the clinical and economic value of genotype-guided aspirin use…”
Get full text

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study by Willis, Connor, Bauer, Hillevi, Au, Trang H, Menon, Jyothi, Unni, Sudhir, Tran, Dao, Rivers, Zachary, Akerley, Wallace, Schabath, Matthew B, Badin, Firas, Sekhon, Ashley, Patel, Malini, Xia, Bing, Gustafson, Beth, Villano, John L, Thomas, John-Michael, Lubinga, Solomon J, Cantrell, Michael A, Brixner, Diana, Stenehjem, David

Get full text

Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center by Stenehjem, David D, Au, Trang H, Ngorsuraches, Surachat, Ma, Junjie, Bauer, Hillevi, Wanishayakorn, Tanatape, Nelson, Ryan S, Pfeiffer, Constance M, Schwartz, Joshua, Korytowsky, Beata, Oderda, Gary, Brixner, Diana I

“…New melanoma therapies have shifted the expectations of patients and providers. Evaluating the impact of treatment characteristics may enhance shared decision…”
Get full text

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study by Willis, Connor, Bauer, Hillevi, Au, Trang H, Menon, Jyothi, Unni, Sudhir, Tran, Dao, Rivers, Zachary, Akerley, Wallace, Schabath, Matthew B, Badin, Firas, Sekhon, Ashley, Patel, Malini, Xia, Bing, Gustafson, Beth, Villano, John L, Thomas, John-Michael, Lubinga, Solomon J, Cantrell, Michael A, Brixner, Diana, Stenehjem, David

“…Tumor mutational burden (TMB) is a potential biomarker to predict tumor response to immuno-oncology agents in patients with metastatic non-small cell lung…”
Get full text

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies by Au, Trang H, Wang, Kai, Stenehjem, David, Garrido-Laguna, Ignacio

“…The advent of next generation sequencing (NGS) technologies has advanced our understanding of the intrinsic biology of different gastrointestinal (GI) tumor…”
Get full text

Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study by Au, Trang H, Willis, Connor, Reblin, Maija, Peters, Katherine B, Nghiemphu, Phioanh Leia, Taylor, Jennie W, Colman, Howard, Cohen, Adam L, Ormond, David Ryan, Neil, Elizabeth C, Chakravarti, Arnab, Willmarth, Nicole, Balajonda, Bea Christine, Menon, Jyothi, Ma, Junjie, Bauer, Hillevi, Nelson, Ryan S, Tan, Malinda S, Singh, Prianka, Marshall, Alexander, Korytowsky, Beata, Stenehjem, David, Brixner, Diana

“…This study aimed to develop a cognitive dysfunction (CD) focused questionnaire to evaluate caregiver burden in glioblastoma. The survey was developed from…”
Get full text

Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma by Au, Trang H., Willis, Connor, Reblin, Maija, Peters, Katherine B., Nghiemphu, Phioanh Leia, Taylor, Jennie W., Colman, Howard, Cohen, Adam L., Ormond, D. Ryan, Chakravarti, Arnab, Willmarth, Nicole, Menon, Jyothi, Ma, Junjie, Bauer, Hillevi, Watanabe, Alexandre H., Ulrich, Cornelia M., Singh, Prianka, Marshall, Alexander, Korytowsky, Beata, Stenehjem, David, Brixner, Diana

Get full text

Ceritinib: A primer for pharmacists by Au, Trang H, Cavalieri, Courtney C, Stenehjem, David D

“…Clinical pharmacists are important contributors to the care of patients with cancer; it is therefore critical for oncology clinical pharmacists to stay current…”
Get full text

Smaller frontal lobe white matter volumes in depressed adolescents by Steingard, Ronald J., Renshaw, Perry F., Hennen, John, Lenox, Mara, Cintron, Christina Bonella, Young, Ashley D., Connor, Daniel F., Au, Trang H., Yurgelun-Todd, Deborah A.

“…Prior studies have demonstrated reduced frontal lobe volumes in depressed adolescents. In this study, frontal lobe gray and white matter volumes in adolescents…”
Get full text

Treatments and outcomes for patients with myelodysplastic syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) scores at the Huntsman Cancer Institute (HCI) by Willis, Connor, Tan, Malinda Sunnita, Bauer, Hillevi, Au, Trang H., Tantravahi, Srinivas Kiran, Gilreath, Jeffrey, Kovacsovics, Tibor, Cao, Xiting, Sadek, Islam, Stenehjem, David D.

“…Abstract only e19034 Background: IPSS-R is used to classify risk of disease progression and guide treatment decisions for patients with MDS. Recent data shows…”
Get full text

Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts by Biltaji, Eman, Au, Trang H., Gligorich, Keith, Bronner, Mary P., Stenehjem, David D., Brixner, Diana I.

“…Abstract only 66 Background: Clinical guidelines recommend RAS testing and BRAF testing in CRC and melanoma, respectively, to guide treatment (tx) decisions…”
Get full text

Cost-effectiveness of genotype-guided aspirin use for colorectal cancer prevention by Biltaji, Eman, Au, Trang H., Walker, Brandon, Ose, Jennifer, Ulrich, Cornelia M, Stenehjem, David D., Brixner, Diana I.

“…Abstract only e18318 Background: Colonoscopy is the “gold standard” for colorectal cancer (CRC) screening. However, adherence rates are low and detection is…”
Get full text

Poster: MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI) by Willis, Connor, Tan, Malinda Sunnita, Bauer, Hillevi, Au, Trang H., Tantravahi, Srinivas Kiran, Gilreath, Jeffrey, Kovacsovics, Tibor, Cao, Xiting, Sadek, Islam, Stenehjem, David D.

Get full text

MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI) by Willis, Connor, Tan, Malinda Sunnita, Bauer, Hillevi, Au, Trang H., Tantravahi, Srinivas Kiran, Gilreath, Jeffrey, Kovacsovics, Tibor, Cao, Xiting, Sadek, Islam, Stenehjem, David D.

“…IPSS-R is used to classify risk of disease progression and guide treatment decisions for patients with MDS. Recent data shows mutational profiling may improve…”
Get full text

Risk of hepatotoxicity with concurrent statin and tyrosine kinase inhibitor (TKI) or mTOR inhibitor (mTORi) in patients with metastatic renal cell carcinoma (mRCC) by Au, Trang H., Bailey, Erin B., Patel, Shiven B., Tantravahi, Srinivas Kiran, Agarwal, Neeraj, Stenehjem, David D.

“…Abstract only 610 Background: TKIs and statins alone can cause liver injury. When used together, there is additive risk for hepatotoxicity, as seen with…”
Get full text